Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation

被引:3
作者
Johns, Emily [1 ]
Vossler, Hillary A. [1 ]
Young, Christina B. [1 ]
Carlson, Mackenzie L. [1 ]
Winer, Joseph R. [1 ]
Younes, Kyan [1 ]
Park, Jennifer [1 ]
Rathmann-Bloch, Julia [2 ]
Smith, Viktorija [1 ]
Harrison, Theresa M. [3 ]
Landau, Susan [3 ]
Henderson, Victor [1 ,4 ]
Wagner, Anthony [3 ,5 ]
Sha, Sharon J. [1 ,5 ]
Zeineh, Michael [6 ]
Zaharchuk, Greg [6 ]
Poston, Kathleen L. [1 ,5 ]
Davidzon, Guido A. [6 ]
Mormino, Elizabeth C. [1 ,5 ]
机构
[1] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, 453 Quarry Rd, Stanford, CA 94304 USA
[2] Stanford Univ, Dept Psychol, Stanford, CA 94304 USA
[3] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA USA
[4] Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA 94304 USA
[5] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94304 USA
[6] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94304 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; biomarkers; clinical trials; neuroimaging; positron emission tomography; BETA PLAQUES; BINDING;
D O I
10.1002/alz.13893
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTION: Amyloid positron emission tomography (PET) acquisition timing impacts quantification. METHODS: In florbetaben (FBB) PET scans of 245 adults with and without cognitive impairment, we investigated the impact of post-injection acquisition time on Centiloids (CLs) across five reference regions. CL equations for FBB were derived using standard methods, using FBB data collected between 90 and 110 min with paired Pittsburgh compound B data. Linear mixed models and t-tests evaluated the impact of acquisition time on CL increases. RESULTS: CL values increased significantly over the scan using the whole cerebellum, cerebellar gray matter, and brainstem as reference regions, particularly in amyloid-positive individuals. In contrast, CLs based on white matter-containing reference regions decreased across the scan. DISCUSSION: The quantification of CLs in FBB PET imaging is influenced by both the overall scan acquisition time and the choice of reference region. Standardized acquisition protocols or the application of acquisition time-specific CL equations should be implemented in clinical protocols. Highlights Acquisition timing affects florbetaben positron emission tomography (PET) scan quantification, especially in amyloid-positive participants. The impact of acquisition timing on quantification varies across common reference regions. Consistent acquisitions and/or appropriate post-injection adjustments are needed to ensure comparability of PET data.
引用
收藏
页码:5299 / 5310
页数:12
相关论文
共 39 条
[1]  
Alzheimer's Association Workgroup, 2023, Revised Criteria for Diagnosis and Staging of Alzheimer's Disease
[2]   Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods [J].
Battle, Mark R. ;
Pillay, Lovena Chedumbarum ;
Lowe, Val J. ;
Knopman, David ;
Kemp, Bradley ;
Rowe, Christopher C. ;
Dore, Vincent ;
Villemagne, Victor L. ;
Buckley, Christopher J. .
EJNMMI RESEARCH, 2018, 8
[3]   Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies [J].
Bourgeat, Pierrick ;
Dore, Vincent ;
Doecke, James ;
Ames, David ;
Masters, Colin L. ;
Rowe, Christopher C. ;
Fripp, Jurgen ;
Villemagne, Victor L. .
NEUROIMAGE, 2021, 226
[4]   Validation of Noninvasive Tracer Kinetic Analysis of 18F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol [J].
Bullich, Santiago ;
Barthel, Henryk ;
Koglin, Norman ;
Becker, Georg A. ;
De Santi, Susan ;
Jovalekic, Aleksandar ;
Stephens, Andrew W. ;
Sabri, Osama .
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (07) :1104-1110
[5]   Optimal Reference Region to Measure Longitudinal Amyloid-β Change with 18F-Florbetaben PET [J].
Bullich, Santiago ;
Villemagne, Victor L. ;
Catafau, Ana M. ;
Jovalekic, Aleksandar ;
Koglin, Norman ;
Rowe, Christopher C. ;
De Santi, Susan .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (08) :1300-1306
[6]   Improved Power for Characterizing Longitudinal Amyloid-β PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region [J].
Chen, Kewei ;
Roontiva, Auttawut ;
Thiyyagura, Pradeep ;
Lee, Wendy ;
Liu, Xiaofen ;
Ayutyanont, Napatkamon ;
Protas, Hillary ;
Luo, Ji Luo ;
Bauer, Robert ;
Reschke, Cole ;
Bandy, Daniel ;
Koeppe, Robert A. ;
Fleisher, Adam S. ;
Caselli, Richard J. ;
Landau, Susan ;
Jagust, William J. ;
Weiner, Michael W. ;
Reiman, Eric M. .
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (04) :560-566
[7]  
Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4
[8]   Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies [J].
Heeman, Fiona ;
Yaqub, Maqsood ;
Alves, Isadora Lopes ;
Heurling, Kerstin ;
Berkhof, Johannes ;
Gispert, Juan Domingo ;
Bullich, Santiago ;
Foley, Christopher ;
Lammertsma, Adriaan A. .
EJNMMI RESEARCH, 2019, 9 (1) :1-14
[9]   Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection [J].
Ikonomovic, Milos D. ;
Buckley, Chris J. ;
Heurling, Kerstin ;
Sherwin, Paul ;
Jones, Paul A. ;
Zanette, Michelle ;
Mathis, Chester A. ;
Klunk, William E. ;
Chakrabarty, Aruna ;
Ironside, James ;
Ismail, Azzam ;
Smith, Colin ;
Thal, Dietmar R. ;
Beach, Thomas G. ;
Farrar, Gill ;
Smith, Adrian P. L. .
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 :130
[10]   NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease [J].
Jack, Clifford R., Jr. ;
Bennett, David A. ;
Blennow, Kaj ;
Carrillo, Maria C. ;
Dunn, Billy ;
Haeberlein, Samantha Budd ;
Holtzman, David M. ;
Jagust, William ;
Jessen, Frank ;
Karlawish, Jason ;
Liu, Enchi ;
Luis Molinuevo, Jose ;
Montine, Thomas ;
Phelps, Creighton ;
Rankin, Katherine P. ;
Rowe, Christopher C. ;
Scheltens, Philip ;
Siemers, Eric ;
Snyder, Heather M. ;
Sperling, Reisa ;
Elliott, Cerise ;
Masliah, Eliezer ;
Ryan, Laurie ;
Silverberg, Nina .
ALZHEIMERS & DEMENTIA, 2018, 14 (04) :535-562